A significant new longitudinal study suggests a compelling association between higher vitamin D levels in midlife and reduced accumulation of…
Read More
Midlife Vitamin D Levels Linked to Lower Alzheimer’s Tau Biomarker; Study Signals Implications for Clinical Labs
A groundbreaking longitudinal study, published on April 1, 2026, in Neurology Open Access, an official journal of the American Academy…
Read More
Daiichi Sankyo Partners with Waiv to Accelerate Digital Pathology Biomarker Discovery for Antibody-Drug Conjugate Programs
In a strategic move to enhance precision in oncology drug development, Japanese pharmaceutical giant Daiichi Sankyo has announced a significant…
Read More
Midlife Vitamin D Levels Linked to Lower Alzheimer’s Tau Biomarker; Study Signals Implications for Clinical Labs
The persistent and growing global challenge of neurodegenerative diseases, particularly Alzheimer’s disease, has intensified the search for modifiable risk factors…
Read More
Midlife Vitamin D Levels Linked to Lower Alzheimer’s Tau Biomarker; Study Signals Implications for Clinical Labs
A landmark longitudinal study, published on April 1, 2026, in Neurology Open Access, an official journal of the American Academy…
Read More
Biomarker Battles: Clinicians Champion Surrogate Endpoints Amidst Regulatory Caution
The complex interplay between clinical trial methodologies and regulatory approval pathways is currently being shaped by a vigorous debate surrounding…
Read More
Midlife Vitamin D Levels Linked to Lower Alzheimer’s Tau Biomarker; Study Signals Implications for Clinical Labs
A groundbreaking longitudinal study, published on April 1, 2026, in Neurology Open Access, an official journal of the American Academy…
Read More
Midlife Vitamin D Levels Linked to Lower Alzheimer’s Tau Biomarker; Study Signals Implications for Clinical Labs
A groundbreaking new longitudinal study, published April 1, 2026, in Neurology Open Access, an official journal of the American Academy…
Read More
